Azevan Pharmaceuticals Inc is a clinical stage drug development company based in Bethlehem, PA, specializing in the development of novel therapeutics for stress-related Central Nervous System (CNS) disorders and neurodegenerative conditions.
The company's focus lies in the development of small molecule drugs that selectively block the effects of arginine vasopressin, a peptide neurohormone involved in various disorders, including neuropsychiatric symptoms in neurodegenerative diseases, Intermittent Explosive Disorder, and PTSD, offering a promising new mechanism of action for addressing these indications.
Generated from the website